Categories
Tags
Inflammatory Bowel Diseases
- DateMay 8, 2023Reactive oxygen species (ROS) are by-products of normal cellular metabolism with low to moderate amounts being beneficial in several physiological processes in the intestine. Chemotherapy and radiotherapies are largely based upon ROS generation to destroy malignant cells by inducing apoptosis…
Moderators
Boston Children's HospitalUniv of Illinois at Chicago - DateMay 9, 2023Visceral pain is a leading cause of disability worldwide, affecting 20% of the population. Increased sensitivity to normal innocuous stimuli in the intestine is a hallmark of many organic and functional gastrointestinal disorders…
Moderators
APHPMcMaster University - DateMay 7, 2023The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children…
Moderators
McMaster UniversityUniversity of Central Lancashire, UK - DateMay 8, 2023This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format…
Moderators
University of Virginia Health SystemMassachusetts General Hospital - DateMay 8, 2023This session will provide attendees with an overview of physician advocacy, how it impacts the GI community and how to get involved…
Moderators
University of WashingtonDuke University School of Medicine - DateMay 9, 2023This session brings Chinese speaking experts together to provide a broad overview highlighting the best of AGA programming at Digestive Disease Week® (DDW) 2023 for Chinese speaking audiences…
Moderator
University of Michigan - DateMay 7, 2023There are multiple new biologic agents that have been approved for the management of IBD over the past few years. In addition, high quality randomized controlled trials have examined optimization of these treatments through therapeutic drug monitoring…
Moderators
Icahn School of Medicine, Mount SinaiNorthwestern Feinberg School of Medicine - DateMay 7, 2023In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis…
Moderators
Cleveland Clinicucsf - DateMay 8, 2023Management of diseases of the ileo-anal pouch and perianal Crohn’s disease is challenging and involves multidisciplinary medical and surgical care. This session review the contemporary management of these complex clinical situations…
Moderators
Swedish Medical CenterMayo Clinic, Rochester - DateMay 6, 2023State of the art - omic methods now provide deeper insight into the biologic architecture of IBD. This session will review state of the art advances in metabolomics, transcriptomics, and epigenetics in defining the biologic basis of IBD…
Moderators
University of California, San FranciscoBrigham and Women's Hospital - DateMay 6, 2023The burden of IBD is rising globally. This session aims to understand the role of genetics in the development of IBD in diverse populations and define the pre-disease state in IBD. It will also explore the emerging field of multi-omics to clinically characterize IBD…
Moderators
University of Otago, ChristchurchIcahn School of Medicine at Mount Sinai - DateMay 8, 2023Microbiome science in the gut has focused on the study of colonic, and more frequently, fecal communities. While the upper gastrointestinal tract has significantly lower bacterial density than the colon, it still harbors a dynamic microbial community…
Moderators
University of California Los AngelesMidwestern University - DateMay 6, 2023The role of nutrition and the microbiome is evident in IBD and functional bowel disorders. The microbiome can affect the way nutrients are metabolized in bioactive components. It is of important to understand the molecular sensors of such metabolized components…
Moderators
McMaster University - DateMay 6, 2023This session highlights thecurrent FDA approved microbiome therapeutics and their applications and the exciting avenues being pursued for the next generation of microbiome therapeutics using gene editing and synthetic microbial communities…
Moderators
Cedars-Sinai Medical CenterPenn Medicine - DateMay 6, 2023Through the history of gut microbiome research, basic, translational, and clinical studies revealed many critical roles played by gut-resident bacteria in affecting human health and disease…
Moderators
McMaster UniversityUniversity of California San Diego - DateMay 7, 2023SOCIETY: AGA
Moderators
Brigham and Women's HospitalUniversity of Massachusetts Medical School - DateMay 8, 2023SOCIETY: AGA
Moderators
ucsfMassachusetts General Hospital - DateMay 7, 2023SOCIETY: DDW
Moderators
University of Chicago Division of the Biological SciencesMayo Clinic Rochester - DateMay 7, 2023SOCIETY: AGA
Moderators
Johns HopkinsWeill Cornell Medicine - DateMay 7, 2023SOCIETY: AGA
Moderators
Katholieke Universiteit Leuven Universitaire Ziekenhuizen LeuvenCedars-Sinai Medical Center - DateMay 8, 2023SOCIETY: AGA
Moderators
Örebro UniversityUniversity of Michigan - DateMay 8, 2023SOCIETY: AGA
Moderators
Cleveland Clinic FoundationCase Western Reserve University School of Medicine - DateMay 8, 2023SOCIETY: AGA
Moderators
Yale School of MedicineUniversity Hospitals Leuven - DateMay 9, 2023SOCIETY: AGA
Moderators
University of North CarolinaUniversity of North Carolina System